(1->4)-beta-D-glucan multiple interactions ISO Arhgap22 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARHGAP22 mRNA CTD PMID:36331819 1,2-dimethylhydrazine increases expression ISO Arhgap22 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of ARHGAP22 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO Arhgap22 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of ARHGAP22 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO Arhgap22 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARHGAP22 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO ARHGAP22 (Homo sapiens) 6480464 Estradiol results in increased expression of ARHGAP22 mRNA CTD PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Arhgap22 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARHGAP22 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ARHGAP22 mRNA CTD PMID:33387578 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Arhgap22 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ARHGAP22 mRNA CTD PMID:21570461 2,4-diaminotoluene increases expression ISO Arhgap22 (Mus musculus) 6480464 2 and 4-diaminotoluene results in increased expression of ARHGAP22 mRNA CTD PMID:20713471 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO ARHGAP22 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARHGAP22 mRNA CTD PMID:28628672 3-methylcholanthrene increases expression ISO Arhgap22 (Mus musculus) 6480464 Methylcholanthrene results in increased expression of ARHGAP22 mRNA CTD PMID:20713471 3-methylcholanthrene multiple interactions ISO ARHGAP22 (Homo sapiens) 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to ARHGAP22 promoter] CTD PMID:20348232 4,4'-sulfonyldiphenol increases expression ISO Arhgap22 (Mus musculus) 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ARHGAP22 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol decreases methylation ISO ARHGAP22 (Homo sapiens) 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of ARHGAP22 gene CTD PMID:31601247 4-hydroxynon-2-enal increases expression ISO Arhgap22 (Mus musculus) 6480464 4-hydroxy-2-nonenal results in increased expression of ARHGAP22 mRNA CTD PMID:19191707 acetamide increases expression EXP 6480464 acetamide results in increased expression of ARHGAP22 mRNA CTD PMID:31881176 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ARHGAP22 mRNA CTD PMID:25378103 aflatoxin B1 affects methylation ISO ARHGAP22 (Homo sapiens) 6480464 Aflatoxin B1 affects the methylation of ARHGAP22 intron CTD PMID:30157460 Aflatoxin B2 alpha affects methylation ISO ARHGAP22 (Homo sapiens) 6480464 aflatoxin B2 affects the methylation of ARHGAP22 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO ARHGAP22 (Homo sapiens) 6480464 Tretinoin results in decreased expression of ARHGAP22 mRNA CTD PMID:23724009 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of ARHGAP22 gene CTD PMID:35440735 benzo[a]pyrene decreases expression ISO ARHGAP22 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of ARHGAP22 mRNA CTD PMID:20064835 benzo[a]pyrene decreases methylation ISO ARHGAP22 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of ARHGAP22 3' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO ARHGAP22 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of ARHGAP22 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO Arhgap22 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of ARHGAP22 mRNA CTD PMID:20713471 and PMID:22228805 benzo[a]pyrene diol epoxide I affects expression ISO ARHGAP22 (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene decreases expression ISO Arhgap22 (Mus musculus) 6480464 benzo(b)fluoranthene results in decreased expression of ARHGAP22 mRNA CTD PMID:26377693 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ARHGAP22 mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO ARHGAP22 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of ARHGAP22 gene CTD PMID:31601247 bisphenol A increases expression ISO Arhgap22 (Mus musculus) 6480464 bisphenol A results in increased expression of ARHGAP22 mRNA CTD PMID:30245210 and PMID:32156529 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ARHGAP22 mRNA CTD PMID:30816183 more ... bisphenol A multiple interactions ISO ARHGAP22 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of ARHGAP22 gene and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARHGAP22 mRNA CTD PMID:28628672 and PMID:31601247 bisphenol F decreases expression ISO Arhgap22 (Mus musculus) 6480464 bisphenol F results in decreased expression of ARHGAP22 mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO ARHGAP22 (Homo sapiens) 6480464 [bisphenol F co-treated with Fulvestrant] results in increased methylation of ARHGAP22 gene CTD PMID:31601247 butanal increases expression ISO ARHGAP22 (Homo sapiens) 6480464 butyraldehyde results in increased expression of ARHGAP22 mRNA CTD PMID:26079696 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of ARHGAP22 promoter CTD PMID:22457795 chlorpyrifos increases expression ISO Arhgap22 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of ARHGAP22 mRNA CTD PMID:32715474 choline multiple interactions ISO Arhgap22 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGAP22 mRNA CTD PMID:20938992 cisplatin decreases expression ISO ARHGAP22 (Homo sapiens) 6480464 Cisplatin results in decreased expression of ARHGAP22 mRNA CTD PMID:19561079 cisplatin increases expression ISO ARHGAP22 (Homo sapiens) 6480464 Cisplatin results in increased expression of ARHGAP22 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO ARHGAP22 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of ARHGAP22 mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO ARHGAP22 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of ARHGAP22 mRNA CTD PMID:22941251 copper atom multiple interactions ISO ARHGAP22 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ARHGAP22 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO ARHGAP22 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ARHGAP22 mRNA CTD PMID:20971185 dexamethasone decreases expression ISO Arhgap22 (Mus musculus) 6480464 Dexamethasone results in decreased expression of ARHGAP22 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO ARHGAP22 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARHGAP22 mRNA CTD PMID:28628672 dexamethasone decreases expression ISO ARHGAP22 (Homo sapiens) 6480464 Dexamethasone results in decreased expression of ARHGAP22 mRNA CTD PMID:25047013 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ARHGAP22 mRNA CTD PMID:21266533 dorsomorphin multiple interactions ISO ARHGAP22 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGAP22 mRNA CTD PMID:27188386 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of ARHGAP22 mRNA CTD PMID:29391264 folic acid multiple interactions ISO Arhgap22 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGAP22 mRNA CTD PMID:20938992 fulvestrant multiple interactions ISO ARHGAP22 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of ARHGAP22 gene and [bisphenol F co-treated with Fulvestrant] results in increased methylation of ARHGAP22 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of ARHGAP22 mRNA CTD PMID:27387713 genistein increases expression ISO Arhgap22 (Mus musculus) 6480464 Genistein results in increased expression of ARHGAP22 mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ARHGAP22 mRNA CTD PMID:33387578 glyphosate decreases methylation EXP 6480464 glyphosate results in decreased methylation of ARHGAP22 gene CTD PMID:31011160 glyphosate affects methylation EXP 6480464 glyphosate affects the methylation of ARHGAP22 gene CTD PMID:35440735 hydrogen peroxide affects expression ISO ARHGAP22 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of ARHGAP22 mRNA CTD PMID:20044591 indometacin multiple interactions ISO ARHGAP22 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARHGAP22 mRNA CTD PMID:28628672 L-methionine multiple interactions ISO Arhgap22 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGAP22 mRNA CTD PMID:20938992 lead(0) increases expression ISO ARHGAP22 (Homo sapiens) 6480464 Lead results in increased expression of ARHGAP22 mRNA CTD PMID:19921347 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ARHGAP22 mRNA CTD PMID:28801915 N-nitrosodiethylamine increases expression ISO Arhgap22 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of ARHGAP22 mRNA CTD PMID:24535843 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of ARHGAP22 mRNA CTD PMID:23665939 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of ARHGAP22 mRNA CTD PMID:25729387 paracetamol affects expression ISO Arhgap22 (Mus musculus) 6480464 Acetaminophen affects the expression of ARHGAP22 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ARHGAP22 mRNA CTD PMID:33387578 pentanal increases expression ISO ARHGAP22 (Homo sapiens) 6480464 pentanal results in increased expression of ARHGAP22 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid multiple interactions ISO Arhgap22 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARHGAP22 mRNA CTD PMID:36331819 phenylmercury acetate decreases expression ISO ARHGAP22 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of ARHGAP22 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO ARHGAP22 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGAP22 mRNA CTD PMID:27188386 pirinixic acid increases expression ISO Arhgap22 (Mus musculus) 6480464 pirinixic acid results in increased expression of ARHGAP22 mRNA CTD PMID:23811191 potassium chromate increases expression ISO ARHGAP22 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of ARHGAP22 mRNA CTD PMID:22714537 propanal increases expression ISO ARHGAP22 (Homo sapiens) 6480464 propionaldehyde results in increased expression of ARHGAP22 mRNA CTD PMID:26079696 SB 431542 multiple interactions ISO ARHGAP22 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGAP22 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO ARHGAP22 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of ARHGAP22 mRNA CTD PMID:25895662 sodium arsenite affects methylation ISO ARHGAP22 (Homo sapiens) 6480464 sodium arsenite affects the methylation of ARHGAP22 gene CTD PMID:28589171 sodium arsenite increases expression ISO ARHGAP22 (Homo sapiens) 6480464 sodium arsenite results in increased expression of ARHGAP22 mRNA CTD PMID:29301061 sodium dichromate decreases expression ISO ARHGAP22 (Homo sapiens) 6480464 sodium bichromate results in decreased expression of ARHGAP22 mRNA CTD PMID:17685462 Soman increases expression EXP 6480464 Soman results in increased expression of ARHGAP22 mRNA CTD PMID:19281266 tamoxifen affects expression ISO Arhgap22 (Mus musculus) 6480464 Tamoxifen affects the expression of ARHGAP22 mRNA CTD PMID:17555576 temozolomide decreases expression ISO ARHGAP22 (Homo sapiens) 6480464 Temozolomide results in decreased expression of ARHGAP22 mRNA CTD PMID:31758290 testosterone increases expression ISO ARHGAP22 (Homo sapiens) 6480464 Testosterone results in increased expression of ARHGAP22 mRNA CTD PMID:33359661 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ARHGAP22 mRNA CTD PMID:23411599 titanium dioxide increases expression ISO Arhgap22 (Mus musculus) 6480464 titanium dioxide results in increased expression of ARHGAP22 mRNA CTD PMID:23557971 triclosan increases expression ISO ARHGAP22 (Homo sapiens) 6480464 Triclosan results in increased expression of ARHGAP22 mRNA CTD PMID:30510588 valproic acid affects expression ISO Arhgap22 (Mus musculus) 6480464 Valproic Acid affects the expression of ARHGAP22 mRNA CTD PMID:17292431 valproic acid increases methylation ISO ARHGAP22 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of ARHGAP22 gene CTD PMID:29154799 valproic acid affects expression ISO ARHGAP22 (Homo sapiens) 6480464 Valproic Acid affects the expression of ARHGAP22 mRNA CTD PMID:25979313 valproic acid increases expression ISO ARHGAP22 (Homo sapiens) 6480464 Valproic Acid results in increased expression of ARHGAP22 mRNA CTD PMID:24935251 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of ARHGAP22 mRNA CTD PMID:20566332 vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of ARHGAP22 gene CTD PMID:31682807 zoledronic acid increases expression ISO ARHGAP22 (Homo sapiens) 6480464 zoledronic acid results in increased expression of ARHGAP22 mRNA CTD PMID:24714768